Relationship Between Premorbid Functioning and Symptom Severity As Assessed at First Episode of Psychosis
Relationship Between Premorbid Functioning and Symptom Severity As Assessed at First Episode of Psychosis
Relationship Between Premorbid Functioning and Symptom Severity As Assessed at First Episode of Psychosis
Method
The data presented here were derived from a retrospective premorbid assessment and the baseline assessment of subjects enrolled in a multicenter double-blind, randomized, controlled trial
comparing a typical and a novel antipsychotic drug in the treatment of first-episode psychosis.
Subjects
The trial is being conducted in 11 countries and has enrolled
psychotic patients between the ages of 16 and 45 years who have
had a DSM-IV diagnosis, based on the Structured Clinical Interview for DSM-IV (5), of schizophrenia, schizophreniform disorder, or schizoaffective disorder for less than 12 months and have
had a maximum of two lifetime psychiatric hospitalizations for
psychosis. The cumulative exposure to neuroleptics could not
have exceeded 12 weeks. The study was conducted according to
Good Clinical Practice guidelines and was approved by local institutional review boards. All subjects gave written informed consent before participating in the study.
The final study group included 535 persons (155 female subjects, median age=25.0 years; 380 male subjects, median age=23.8
years). Two persons left the trial before treatment but after random assignment, and 21 patients were excluded because the cen-
2021
Patients (N=531)
Life Stage
Childhood (11 years)
Early adolescence (1215 years)
Late adolescence (1618 years)
Adulthood (>18 years)
Most recent life stage
All life stages
Mean
0.28
0.32
0.39
0.42
0.41
0.36
SD
0.18
0.17
0.20
0.24
0.19
0.15
Comparison Subjects
(N=76)b
Mean
0.23
0.21
0.17
0.12
0.09
0.16
SE
0.01
0.01
0.01
0.01
0.01
0.01
Cumulative %
42.4
25.6
10.7
5.2
the healthy comparison subjects by Cannon-Spoor et al. (6). The comparison subjects
provided the normative data used to validate the Premorbid Adjustment Scale.
ter where they were treated was removed from the trial owing to
inconsistent data reporting. Patients were assigned the following
DSM-IV diagnoses: schizophrenia (N=264), schizophreniform
disorder (N=231), and schizoaffective disorder (N=40). Threequarters of the study group were white (N=400), 12% (N=64) were
black, 3% (N=17) were Hispanic, 2% (N=11) were Oriental, and 8%
(N=43) were from assorted other groups. Fourteen percent (N=76)
of the study group had no high school education, 27% (N=141)
had some high school education, 21% (N=114) completed high
school, 30% (N=159) completed some posthigh school education, and 8% (N=41) completed college. (Data on education were
missing for four subjects.) Female subjects were significantly
older than male subjects at the time they first experienced psychotic symptoms (median=23.9 versus 22.6 years, Mann-Whitney
U=24154, z=2.89, p=0.004). Eighty-eight percent of the patients
(N=471) were 18 or older at the time of onset of first psychotic
symptoms.
Assessments
The current analysis included data from a cognitive assessment and administration of the Premorbid Adjustment Scale (6),
the Positive and Negative Syndrome Scale (7), and the Clinical
Global Impression (CGI) severity scale (8). All measures were applied at baseline before administration of the trial drug.
The Premorbid Adjustment Scale is a 28-item rating scale that
assesses sociability and withdrawal, peer relationships, adaptation to school, and scholastic performance for four life stages
(childhood, 11 years and younger; early adolescence, 1215 years;
late adolescence, 1618 years; and adulthood, older than 18
years), as well as social-sexual aspects of life after age 15. The Premorbid Adjustment Scale also includes a section of nine general
items relating to educational and job achievement, work and
school performance immediately preceding onset of psychosis,
highest level of independence from family, highest level of social
personal adjustment, degree of interest in life, and energy level.
The Premorbid Adjustment Scale was completed on the basis of
all available data, including data from interviews with the patient
and with collateral informants, if they were available.
The cognitive assessment, which is described in greater detail
elsewhere (9), included the 1) Wechsler Memory ScaleRevised
visual reproduction subtest I and II (10), a test of learning memory for nonverbal stimuli; 2) Rey Auditory Verbal Learning Test
(11), a test of verbal learning and memory; 3) Continuous Performance Test, Identical Pairs Version (12), a test of vigilance; 4) verbal fluency examinations, including tests of category and phonological fluency (13), a test of verbal productivity and intactness of
the lexical system; 5) Wechsler Adult Intelligence ScaleRevised,
digit symbol subtest (14), a test of psychomotor speed and attention; and 6) Wisconsin Card Sorting Test (15), a measure of executive functioning (e.g., cognitive flexibility, maintenance of a cognitive set, working memory). The tests, which were carefully
2022
Analytic Plan
Data for each of the five Premorbid Adjustment Scale dimensions across the four life stages were analyzed with a repeated
measures analysis of variance (ANOVA), controlling for gender
and diagnosis. A separate general linear model multivariate analysis of variance (GLM MANOVA) was done for each dimension
because all dimensions were not measured at every life stage (e.g.,
social-sexual aspects of life were not measured for childhood, and
adaptation to school was not measured for adults). By using the
scoring method developed by Cannon-Spoor et al. (6), average
scores for each life stage were computed by summing the scores
received for each item in a section and dividing them by the possible score. The sum of the maximum possible score for all items
completed indicates the highest score obtainable. Thus, for exAm J Psychiatry 159:12, December 2002
For a normative comparison, we used the normative data provided by Cannon-Spoor et al. (6). The mean score of the normal
subjects was used to create a variable of normal functioning (versus below-normal functioning) in each of the four life stages. Premorbid functioning was described by using the classification
method of Haas and Sweeney (16), which included the following
categories: stablegood, stablepoor, and deteriorating premorbid functioning. Deteriorating premorbid functioning, in terms of
the Premorbid Adjustment Scale, was defined as a pattern of
worsening scores from childhood over the remaining premorbid
periods and the equivalent of a 2-point change over four premorbid stages (childhood, early adolescence, late adolescence, and
adulthood) or a proportional decline for cases in which illness onset was before late adolescence or adulthood. The remaining patients were regarded as stable, and the median value (0.36) of the
Premorbid Adjustment Scale total score was used as a cutoff point
to assign these patients to stablegood or stablepoor groups.
Data for patients were aggregated on this scale of premorbid
functioning, and the three groups were compared on symptom
and cognitive measures by using GLM MANOVA with diagnosis,
sex, and exposure to antipsychotics as factors. Bonferroni-corrected significance levels for between-group differences are reported. The Bonferroni correction consisted of multiplying each
p value by 3, since three comparisons were made (e.g., p=0.05
with Bonferroni correction is presented as p=0.15).
Results
Table 1 presents the subjects mean scores on the Premorbid Adjustment Scale for each life stage. The normative
data on healthy comparison subjects from the work of Cannon-Spoor et al. (6) are also shown in Table 1. The mean
score for childhood for the patients in this study was 0.28,
which was somewhat higher (reflecting worse functioning)
than that for the healthy comparison subjects, who had a
mean score of 0.23. Of the patients in this study, 42.4% had
scores for the childhood period that were no worse than the
mean score for the healthy comparison subjects. The mean
score differences between the patients and the comparison
subjects increased with each successive time period, and
concomitantly the percentage of patients with normal
functioning decreased during subsequent periods. The last
column of Table 1 shows the cumulative percentage of patients who functioned within the normal range for each life
stage and the preceding stages.
Figure 1 presents the patients mean scores on the Premorbid Adjustment Scale across the four life stages assessed. A repeated measures ANOVA comparing these
scores across the life stages found an overall significant
difference and a significant linear trend (decline) on all
five dimensions measured (sociability and withdrawal: F=
32.1, df=3, 1383, p<0.0001 and F=53.2, df=1, 461, p<0.0001;
peer relationships: F=29.6, df=3, 1383, p<0.0001 and F=
47.6, df=1, 461, p<0.0001; scholastic performance: F=35.7,
Am J Psychiatry 159:12, December 2002
3.5
Mean Score on Premorbid Adjustment Scale
Scholastic performance
Peer relationships
Sociability and withdrawal
Adaptation to school
Social-sexual aspects of life
3.0
2.5
2.0
1.5
1.0
011
1215
1618
>18
Age (years)
a
df=2, 988, p<0.0001 and F=48.8, df=1, 494, p<0.0001; adaptation to school: F=51.5, df=2, 978, p<0.0001 and F=74.6,
df=1, 489, p<0.0001; and social-sexual aspects: F=32.7, df=
2, 878, p<0.0001 and F=47.5, df=1, 439, p<0.0001).
Using the method of Haas and Sweeney (16), 47.5% of
the subjects (N=252) were categorized as having stable
good premorbid functioning; 37.3% (N=198) as having stablepoor functioning; and 15.3% (N=81) as having deteriorating premorbid functioning. Although the Haas scale is
based on a different method of computation (described in
detail in the section on data analysis) than the method
used to compare the overall group of patients to the comparison subjects, the stablegood group had mean scores
that were similar to those of the comparison subjects (reported in Table 1) for childhood and early adolescence
(childhood: 0.19 and 0.23, respectively; early adolescence:
0.21 and 0.21, respectively) and different from those of the
comparison subjects for late adolescence and adulthood
scores (late adolescence: 0.24 versus 0.17; adulthood: 0.24
versus 0.12).
Female subjects had significantly better premorbid
functioning (stablegood: 57%, N=88; stablepoor: 34%,
N=53; deteriorating: 9%, N=14) than male subjects (stablegood: 44%, N=164; stablepoor: 18%, N=67; deteriorating 39%, N=145) (2=10.1, df=2, p=0.006). Patients with
a diagnosis of schizophreniform disorder had better premorbid functioning (stablegood: 62%, N=143; stable
poor: 27%, N=61; deteriorating: 11%, N=25) than those
2023
Patients With
Deteriorating
Premorbid
Functioning (N=81)
Mean
95% CI
Mean
95% CI
Mean
95% CI
Measure
Symptom severity c
Positive and Negative Syndrome Scale
Positive syndrome score
19.8
18.820.7
20.5
19.022.0
21.1
20.122.1
Negative syndrome score
19.9
18.821.0
24.0
22.325.6
23.0
22.024.2
General psychopathology score
39.2
37.540.8
42.4
39.945.0
42.7
41.044.5
Clinical Global Impression severity scale score
4.5
4.34.6
4.6
4.44.8
4.7
4.54.8
Cognitive functioning d
Wechsler Memory ScaleRevised visual reproduction
Immediate recall score
31.5
30.332.8
32.0
30.033.9
29.9
28.631.2
Delayed recall score
28.1
26.429.7
27.7
25.230.3
25.2
23.527.0
Rey Auditory Verbal Learning Test score
44.5
42.446.9
46.8
43.650.1
42.9
40.745.1
Continuous Performance Test
0.8
0.60.9
1.0
0.81.2
0.7
0.60.8
Verbal fluency examinations
Category total score
39.0
37.141.1
41.4
38.444.4
37.4
35.439.5
Letter total score
31.3
29.032.8
31.2
28.234.3
30.3
28.232.4
Wechsler Adult Intelligence Scale-Revised digit symbol test score
45.6
43.247.9
49.0
45.452.7
44.9
42.447.3
Wisconsin Card Sorting Test
Categories
4.3
3.94.7
4.3
3.74.9
3.7
3.34.0
41.2
36.945.4
38.5
32.045.0
48.1
43.752.5
Total errors
a Premorbid functioning was defined in terms of Premorbid Adjustment Scale scores, according to the typology of Haas and Sweeney (16).
Deteriorating functioning was a pattern of worsening Premorbid Adjustment Scale scores from childhood over the remaining premorbid life
stages and the equivalent of a 2-point change over the four premorbid life stages or a proportional decline for patients whose illness onset
was before late adolescence or adulthood. Patients without this pattern were regarded as stable; the median value (0.36) of the Premorbid
Adjustment Scale total score was used as a cutoff point to assign these patients to the stablegood or the stablepoor group.
b Bonferroni correction done by multiplying t test significance level by 3, since three comparisons were made.
c Significant difference between groups in overall symptom severity (F=4.0, df=8, 1038, p<0.0001).
d Significant difference between groups in overall cognitive functioning (F=1.7, df=18, 850, p=0.03).
2024
CGI, and significantly worse scores on one cognitive measure. The stablepoor group had significantly worse performance on three cognitive measures, compared to the
deteriorating group, but the scores on the CGI and Positive
and Negative Syndrome Scale were not different between
those groups.
Discriminant function analysis with the stepwise procedure based on Wilkss lambda was conducted to examine
the relative importance of scores on the Positive and Negative Syndrome Scale subscales, the CGI, and the cognitive
variables in discriminating between the three types of premorbid adjustment. The two variables that significantly
discriminated between the groups were the Positive and
Negative Syndrome Scale negative subscale score, which
was the first variable entered in the model (F=18.9, df=2,
434, p<0.0001), and the score on the category test of the
verbal fluency examinations, which was the second variable added to the model (F=12.3, df=4, 866, p<0.0001).
Discussion
More than half of the subjects in this study, who were experiencing a first episode of psychosis, had some disturbances long before the episode. Although 88% of the patients had onset of psychosis after age 18, 84% showed a
disturbance in functioning, relative to the functioning of
normal comparison subjects, before age 18, almost 70%
before age 15, and 58% before age 11. Poorer premorbid
Am J Psychiatry 159:12, December 2002
Analysis
Between-Group Differences (p)b
2.6
15.4
7.0
2.6
df
0.003
<0.0001
<0.0001
0.001
0.23
<0.0001
0.008
0.06
1.00
0.76
1.00
1.00
0.05
0.02
0.08
0.007
0.10
0.04
0.51
1.00
1.00
1.00
0.77
0.01
0.14
0.22
0.11
0.004
3.0 2, 439
0.4 2, 439
2.2 2, 439
0.05
0.68
0.11
0.94
1.00
1.00
0.28
1.00
0.4
0.06
1.00
0.20
4.9 2, 439
5.1 2, 439
0.008
0.006
0.02
0.05
1.00
1.00
0.10
0.02
3.0
4.1
2.6
5.0
2, 528 0.08
2, 528 <0.0001
2, 528 <0.0001
2, 528 0.07
2, 439
2, 439
2, 439
2, 439
The results presented here indicate that, as a group, individuals affected by psychosis are likely to show continuous deterioration of social functioning from childhood
through adolescence, as the first episode of psychosis approaches. However, only 15% of the subjects (those with
deteriorating premorbid functioning) showed a clear transition from a higher to a lower level of social functioning.
Hence the data lend tentative support to the existence of a
subgroup of patients with gradual premorbid social deterioration and a subgroup who lack developmental progress.
Limitations of the data in this study and previous studies may account for the variation in findings about the
quality and timing of premorbid manifestations. The data
were limited in part because they were derived from crosssectional assessments conducted at the patients first contact with a mental health professional (20). In addition,
the data were based on the subjective recollections of a variety of sources, including the patient, family members,
and other collateral informants. It is conceivable that a
true prospective follow-up study, specifically designed to
detect signs of premorbid psychosis and schizophrenia
and conducted from birth through age of risk, would reveal a specific trajectory of social maladjustment for the
majority of individuals destined to be affected by psychosis. Alternately, the premorbid and prodromal manifestations may be obligatory precursors of the illness for only
some individuals or for only a subgroup of the schizophrenias. Another limitation of this study is the potential for a
selection bias, given that the data were obtained from patients who agreed to be enrolled in a medication trial.
However, it is not obvious how such a bias might affect the
conclusions that can be drawn from the study.
In this study, approximately half of a group of subjects
with a first episode of psychosis retrospectively reported
poor premorbid social adjustment. This finding is consistent with data that have been collected prospectively. In a
prospective historical study in which social adjustment
was assessed in apparently healthy adolescents, poor social adjustment was reported regarding as many as 44% of
subjects assigned a diagnosis of schizophrenia 1 or more
years (mean=4 years), compared to only 7% of the subjects
of the same age who remained healthy (21). This finding
supports the accuracy of the prevalence of premorbid
maladjustment reported in this study.
The results of this study are consistent with previous reports about first-episode schizophrenia. Most studies in
this area have found that individuals with poorer (as opposed to better) premorbid functioning also have more severe symptoms, as reflected by the negative syndrome
subscale of the Positive and Negative Syndrome Scale and
the CGI, as well as worse cognitive performance, as measured with standard neuropsychological tests. The relationships between the Premorbid Adjustment Scale scores
and the Positive and Negative Syndrome Scale, CGI, and
cognitive scores can be interpreted in a number of ways.
The different scales may assess similar domains, or there
2025
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
References
1. Mohamed S, Paulsen JS, OLeary D, Arndt S, Andreasen N: Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Arch Gen Psychiatry 1999; 56:749754
19.
2. Russell AJ, Munro JC, Jones PB, Hemsley DR, Murray RM: Schizophrenia and the myth of intellectual decline. Am J Psychiatry
1997; 154:635639
20.
21.
2026
decade prior to first hospitalization and early course of psychotic illness. Br J Psychiatry 2000; 177:2632
First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders (SCID), Clinician Version. Washington, DC, American Psychiatric Press, 1996
Cannon-Spoor H, Potkin G, Wyatt J: Measurement of premorbid
adjustment in chronic schizophrenia. Schizophr Bull 1982; 8:
470484
Kay SR, Singh MM: The positive-negative distinction in drugfree schizophrenic patients: stability, response to neuroleptics,
and prognostic significance. Arch Gen Psychiatry 1989; 46:
711718
Guy W (ed): ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Washington, DC, US Department
of Health, Education, and Welfare, 1976, pp 218222
Harvey PD, Artiola L, DeSmedt G: Cross national cognitive assessment in schizophrenia clinical trials: a feasibility study.
Schizophr Res 2002 (in press)
Wechsler D: The Wechsler Memory ScaleRevised. San Antonio, Tex, Psychological Corp, 1987
Spreen O, Strauss E: A Compendium of Neuropsychological
Tests and Norms. New York, Oxford University Press, 1998
Cornblatt BA, Lenzenweger MF, Erlenmeyer-Kimling L: The
Continuous Performance Test, Identical Pairs Version, II: contrasting attentional profiles in schizophrenic and depressed
patients. Psychiatry Res 1989; 29:6585
Lezak MD: Neuropsychological Assessment. New York, Oxford
University Press, 1997
Wechsler D: The Wechsler Adult Intelligence ScaleRevised.
New York, Psychological Corp, 1978
Heaton R, Chelune C, Talley J, Kay G, Curtiss G: Wisconsin Card
Sorting Test ManualRevised and Expanded. Odessa, Fla, Psychological Assessment Resources, 1993
Haas GL, Sweeney JA: Premorbid and onset features of first-episode schizophrenia. Schizophr Bull 1992; 18:373386
Bhugra D, Hilwig M, Mallett R, Corridan B, Leff J, Neehall J,
Rudge S: Factors in the onset of schizophrenia: a comparison
between London and Trinidad samples. Acta Psychiatr Scand
2000; 101:135141
Hinrichsen GA, Lieberman JA: Family attributions and coping
in the prediction of emotional adjustment in family members
of patients with first-episode schizophrenia. Acta Psychiatr
Scand 1999; 100:359366
Varma VK, Wig NN, Phookun HR, Misra AK, Khare CB, Tripathi
BM, Behere PB, Yoo ES, Susser ES: First-onset schizophrenia in
the community: relationship of urbanization with onset, early
manifestations and typology. Acta Psychiatr Scand 1997; 96:
431438
McGlashan TH: A selective review of recent North American
long-term follow-up studies of schizophrenia. Schizophr Bull
1988; 14:515542
Davidson M, Reichenberg A, Rabinowitz J, Weiser M, Kaplan Z,
Mark M: Behavioral and intellectual markers for schizophrenia
in apparently healthy male adolescents. Am J Psychiatry 1999;
156:13281335